tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IPSC Stock Latest News

Century Therapeutics downgraded to Market Perform from Outperform at Leerink
The FlyCentury Therapeutics downgraded to Market Perform from Outperform at Leerink
9d ago
IPSC
Century Therapeutics Reports Positive Q3 2025 Earnings
PremiumCompany Announcements
Century Therapeutics Reports Positive Q3 2025 Earnings
12d ago
IPSC
Century Therapeutics Launches Type 1 Diabetes Program
PremiumCompany Announcements
Century Therapeutics Launches Type 1 Diabetes Program
13d ago
8K
IPSC
Century Therapeutics reports Q3 EPS (40c) vs (37c) last year
PremiumThe Fly
Century Therapeutics reports Q3 EPS (40c) vs (37c) last year
13d ago
IPSC
Century Therapeutics announces new beta islet program for Type 1 diabetes
PremiumThe Fly
Century Therapeutics announces new beta islet program for Type 1 diabetes
13d ago
IPSC
Century Therapeutics’ Long-Term Follow-Up Study: Key Insights for Investors
PremiumCompany AnnouncementsCentury Therapeutics’ Long-Term Follow-Up Study: Key Insights for Investors
30d ago
IPSC
Century Therapeutics’ CALiPSO-1 Study: A Promising Step in Autoimmune Disease Treatment
Premium
Company Announcements
Century Therapeutics’ CALiPSO-1 Study: A Promising Step in Autoimmune Disease Treatment
30d ago
IPSC
Century Therapeutics Granted Nasdaq Compliance Extension
Premium
Company Announcements
Century Therapeutics Granted Nasdaq Compliance Extension
3M ago
8K
IPSC
Century Therapeutics Reports Q2 2025 Financials and Updates
PremiumCompany Announcements
Century Therapeutics Reports Q2 2025 Financials and Updates
3M ago
IPSC
Century Therapeutics: Strategic Workforce Reduction and Financial Position Justify Hold Rating Amid Developmental Progress and Challenges
PremiumRatings
Century Therapeutics: Strategic Workforce Reduction and Financial Position Justify Hold Rating Amid Developmental Progress and Challenges
3M ago
IPSC
Century Therapeutics Reports Q2 Results and Leadership Change
PremiumCompany Announcements
Century Therapeutics Reports Q2 Results and Leadership Change
3M ago
8K
IPSC
Century Therapeutics files $200M mixed securities shelf
PremiumThe Fly
Century Therapeutics files $200M mixed securities shelf
5M ago
IPSC
Century Therapeutics Announces Major Workforce Reduction
PremiumCompany AnnouncementsCentury Therapeutics Announces Major Workforce Reduction
5M ago
8K
IPSC
Century Therapeutics Holds 2025 Annual Stockholders Meeting
Premium
Company Announcements
Century Therapeutics Holds 2025 Annual Stockholders Meeting
5M ago
8K
IPSC
Century Therapeutics Reports Strong Q1 2025 Earnings
Premium
Company Announcements
Century Therapeutics Reports Strong Q1 2025 Earnings
6M ago
IPSC
Century Therapeutics Reports Strong Q1 2025 Financial Results
PremiumCompany Announcements
Century Therapeutics Reports Strong Q1 2025 Financial Results
6M ago
8K
IPSC
Century Therapeutics: Strategic Advancements and Promising Preclinical Data Justify Buy Rating
PremiumRatings
Century Therapeutics: Strategic Advancements and Promising Preclinical Data Justify Buy Rating
7M ago
IPSC
Century Therapeutics price target lowered to $2 from $5 at H.C. Wainwright
PremiumThe Fly
Century Therapeutics price target lowered to $2 from $5 at H.C. Wainwright
8M ago
IPSC
Century Therapeutics price target lowered to $7 from $11 at Chardan
PremiumThe Fly
Century Therapeutics price target lowered to $7 from $11 at Chardan
8M ago
IPSC
Century Therapeutics price target lowered to $5 from $12 at Guggenheim
PremiumThe FlyCentury Therapeutics price target lowered to $5 from $12 at Guggenheim
8M ago
IPSC
Century Therapeutics Reports 2024 Financial Results and Strategic Updates
Premium
Company Announcements
Century Therapeutics Reports 2024 Financial Results and Strategic Updates
8M ago
IPSC
Century Therapeutics price target lowered to $2 from $4 at Piper Sandler
Premium
The Fly
Century Therapeutics price target lowered to $2 from $4 at Piper Sandler
8M ago
IPSC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >